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Abstract 
Aging is an increasingly important research topic due to the aging populations in the United 
States and other developed countries. One aspect of aging, age-related hearing loss, is caused by 
changes in the peripheral and the central auditory systems. The age-related changes in the central 
auditory system, including the integrating midbrain area inferior colliculus (IC), are not well 
understood. Studies have revealed that GABA levels in the IC decrease with age. However, no 
studies have quantified the age-related changes in IC glutamate levels or the relationship 
between GABA and glutamate levels in the aging IC. This study aimed to elucidate the age-
related changes in glutamate levels and to understand the role of the inhibition—excitation 
balance in the aging IC. Auditory brainstem responses (ABR) were collected from four young 
and four aged Fischer-344 rats prior to neural tissue processing. Secondary immunofluorescent 
staining for GAD67 and VGluT2 was performed on 35 µm sections of IC. Confocal images were 
captured at 63x and the GAD67 and VGluT2 images were analyzed separately. We found that 
the staining intensity of both GAD67-immunoreactive (-ir) and VGluT2-ir presynaptic terminals 
decreased significantly with age; however, terminal size was not related to age. Additionally, we 
found a significant relationship between click ABR wave IV amplitude and the GAD67:VGluT2 
ratio for both terminal area and terminal staining intensity, indicating the importance of the 
inhibition—excitation relationship to IC function. This contributes to the understanding of age-
related hearing loss and may be translated into more effective hearing loss treatments.  
Keywords: GABA, glutamate, inferior colliculus, age-related hearing loss, presbycusis, 
inhibition—excitation balance  
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Age-Related Hearing Loss: 
Inhibition-Excitation Balance in the Rat Inferior Colliculus 
Aging and the Brain 
 Aging is a relatively new problem in the span of evolution. Many species live only long 
enough to reproduce and ensure their offspring become self-sufficient (Gross, 2005).  According 
to classic evolutionary theory, there is no reason for an animal to live past its reproductive age; it 
is no longer contributing to the continuation of its genes, and may even be consuming resources 
that could be used to raise its progeny (Raichlen & Alexander, 2014). However, some species do 
live long past the end of their reproductive period (Gross, 2005). For example, about 1.8 million 
years ago the human lifespan began to increase (Raichlen & Alexander, 2014). One leading 
hypothesis for this apparent breach of evolutionary theory is the “grandmother hypothesis” 
(Raichlen & Alexander, 2014). The “grandmother hypothesis” states that individuals may live 
past their own reproductive period if they contribute to the raising of their offspring’s offspring, 
which will increase the fitness and success of their own genes in later generations (Raichlen & 
Alexander, 2014). However, the grandmother hypothesis only applies to the sex that outlives its 
reproductive period: in humans, the females. Other hypotheses focus on the increasing age at 
which humans reach senescence, arguing that life expectancy is increasing simply because 
humans are reaching old age with better health (Vaupel, 2010). More research and careful 
analysis of analysis of genetics and history are required to address this question, though the 
“longevity riddle” may never be solved (Vaupel, 2010). 
 Relatively novel health complications appear and previously rare conditions become 
commonplace as populations age. For instance, during the second half of the 20th century, human 
life expectancy increased by about twenty years and the incidence of cancer increased yearly, 
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peaking in 1992 (Centers for Disease Control and Prevention, 2003; Greenlee et al., 2000). Age 
itself is a major risk factor for disease. One’s risk of developing Type II diabetes is highest 
between 60 and 79 years old; additionally, incidence of Type II diabetes is expected to increase 
the most over the next twenty years in the 60-79 years old age group (Guariguata et al., 2014).  
 Aging also increases one’s risk of developing many neurological diseases. Age is the 
largest risk factor for Alzheimer’s disease (AD), which occurs in one in nine people over the age 
of 65, and one in three people over the age of 85 (Alzheimer’s Association Science Staff, 2015). 
Likewise, the largest risk factor for Parkinson’s disease is aging, and disease severity increases 
significantly with age (Reeve et al., 2014; Szewczyk-Krolikowski et al., 2014). In addition, aging 
causes a decrease in brain function in more generalized, non-pathological ways. For example, 
age-related cognitive decline begins in humans as early as one’s 20s, with cognition decreasing 
in a relatively linear fashion from that point onwards (Salthouse, 2009).  
Age-related cognitive decline is a well-documented phenomenon, although its full 
description and causes are still being debated. One early theory separated cognitive ability and 
intelligence into fluid intelligence, such as short-term memory and ability to learn new skills, and 
crystallized intelligence, such as vocabulary and ability to recall and perform existing skills 
(Hartshorne & Germine, 2015). Researchers believed that fluid intelligence began to decline 
following a peak in early adulthood, while crystalized intelligence began to decline following a 
peak in middle age (Hartshorne & Germine, 2015). However, the specific time course of decline 
posited by this theory has been questioned recently: short-term memory for different items (i.e. 
faces vs. names) appears to peak at different times in the lifespan (Hartshorne & Germine, 2015). 
Another early theory stated that intelligent quotient (IQ), which may or may not actually 
be a measure of intelligence, decreased with age (Sapolsky, 2004). However, the method of 
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testing appears to play a large role in IQ test performance amongst the elderly (Sapolsky, 2004). 
Researchers have demonstrated that when given unlimited time to complete the test, elderly 
individuals performed as well on IQ tests as young individuals; it was the time constraint that 
decreased the performance of elderly individuals in other studies (Sapolsky, 2004).  
The modern Wechsler Adult Intelligence Scales (WAIS) are relatively good measures of 
some types of cognitive ability and age-related cognitive decline (Baxendale, 2011). WAIS use a 
set of different cognitive tests to determine an average full-scale score (FSIQ) (Baxendale, 
2011). The primary individual tests are for verbal comprehension, perceptual reasoning, working 
memory, and processing speed (Baxendale, 2011). The WAIS use age-related scaled scores for 
each area; this allows for an individual to maintain essentially the same FSIQ throughout 
adulthood, despite age-related cognitive changes (Baxendale, 2011). Baxendale examined each 
of the four primary tests individually (2011). Because age-related changes in cognitive ability are 
often different for individuals with different initial intelligence levels, she separated the subjects 
into a high FSIQ group, a standard FSIQ group, and a low FSIQ group (Baxendale, 2011). In all 
groups, she found that verbal comprehension actually increases until middle age and that the 
decline in perceptual reasoning and processing speed begins around age 30-34 (Baxendale, 
2011). The high FSIQ group had larger rates of both development and decline on all tests, but the 
decline, especially in perceptual reasoning and verbal comprehension, is delayed when compared 
with the standard group (Baxendale, 2011).  
Many others have examined exclusively the processing speed decline. Deary and Ritchie 
(2016) recognized, like Baxendale (2011), that initial intelligence could have a relationship with 
cognitive decline and looked at the difference in processing speed in 70 and 83 year olds who 
were matched for childhood IQ. Deary and Ritchie also controlled for health and grip strength, a 
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measure of physical fitness, which have been understandably correlated with successful aging 
(2016). They found a significant difference in processing speed between the two groups, as 
expected. This supports the finding in other studies that processing speed decreases with age (Lu 
et al., 2013). 
Hartshorne and Germine (2015) divided cognitive performance into even more specific 
categories, testing a total of 36 cognitive abilities using the third edition of WAIS and the third 
edition of the Wechsler Memory Scale. They found a vast difference in peak performance age for 
different cognitive abilities, with short term memory (for word pairs, stories, and family photos) 
peaking earliest at about 16 years old, and vocabulary, general knowledge, and comprehension 
peaking latest at about 50 years old. Regardless of the specific details about peak performance 
and onset and rate of decline, it is clear that, like other bodily systems, age-related cognitive 
changes pose important challenges for populations in which a high number of individuals are 
reaching older ages. 
There are many reasons for age-related brain degradation and senescence, of which 
cognitive decline is but one example. Some of the most well understood mechanisms for age-
related decline in neural systems are myelin loss, decrease in neurotransmitter levels, decrease in 
neuron count, and mitochondrial DNA deletions that occur more frequently with age. Myelin 
loss in particular has been connected with a decrease in cognitive processing speed (Lu et al., 
2013). In fact, the relation between myelination loss and cognitive processing speed was 
significant even when data were adjusted for age, suggesting the importance of myelin loss to 
cognitive function (Lu et al., 2013). In vitro, myelinated axons conduct signals up to 100 times 
faster than unmyelinated axons (Waxman, 1977). Additionally, unmyelinated axons often fail to 
conduct, without the myelin to sustain the depolarization across a distance (Waxman, 1977). 
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Hence, myelin deterioration makes communication in neural systems not only less efficient, but 
in some cases completely impossible. 
Myelin levels decrease in normal aging, but those decreases are exaggerated in some 
neurodegenerative diseases (Spadaro & Meinl, 2016). For example, in demyelinating diseases 
like pediatric multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica 
spectrum disorders a body’s immune attacks its own myelin (Spadaro & Meinl, 2016). 
Specifically, it appears that these autoimmune disorders are targeting myelin oligodendrocyte 
glycoprotein (MOG), a protein found on the surface of myelinating cells (Spadaro & Meinl, 
2016). Because MOG is highly conserved, seen in both animal models of the diseases and more 
recently in human patients, hopefully strategies that target MOG will provide a successful path to 
future therapeutic techniques (Spadaro & Meinl, 2016).  
In normal agers, regions that produce myelin later in development lose their myelin 
earlier in degeneration (Lu et al., 2013). In these late myelinating regions, such as the genu of the 
corpus callosum and the frontal lobe, the oliogodendrocytes differentiate later in development 
and thus have less time to develop as myelin (Lu et al., 2013). Thus, myelin in late myelinating 
regions is thinner and more vulnerable to breakdown than that in early myelinating regions, such 
as the splenium of the corpus callosum and the visual pathway (Lu et al., 2013).  
In addition to myelin breakdown, the levels of many neurotransmitters decline with age. 
A major study in 1989 characterized the age-related changes in several neurotransmitters in the 
rhesus monkey (Wenk et al., 1989). The researchers found that all of the major neurotransmitter 
groups—cholingergic, monoaminergic, and amino acid neurotransmitters—had lower levels in 
the aged monkeys than in the young monkeys (Wenk et al., 1989). More recently, studies have 
confirmed parallel findings in humans. For example, dopamine levels were examined using 
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FDOPA PET scans, and were found to decrease with age, primarily in the cortex (Kalbitzer et 
al., 2012).  
Because the dopamine levels found by Kalbitzer et al. (2012) were not correlated with 
gray matter density, the researchers also concluded that the finding was independent from neuron 
atrophy, which also occurs normally during aging. In rhesus monkeys, one of the best models of 
human aging, there is large and significant neuronal atrophy with age (Smith et al., 1999). For 
example, Smith et al. (1999) found that aging is associated with significant cholinergic neuron 
loss in subcortical regions and a 43% loss of neurons that respond to nerve growth factor 
throughout the brain. Another study by the same group found that there was significant atrophy 
in subcortical and cortical regions in aged animals, particularly cortical regions associated with 
age-related cognition and memory decline (Smith et al., 2004). However, age-related neuron loss 
is relatively slow in mammals, as compared with other classes of animals (Burianová et al., 
2015).  
Finally, mitochondrial DNA deletions are known to occur during aging, likely because of 
age-related oxidative stress and free oxygen radicals interfering with the replication activities of 
mitochondria (Seidman et al., 1997). In a study by Seidman et al. (1997), 0-10% of young and 
middle-aged Fischer-344 rats showed common mitochondrial DNA deletions, while 88-100% of 
rats over 18 months possessed the common deletions. Likewise, Wang et al. (2006) found a high 
frequency of mitochondrial DNA mutations in postmortem brains of elderly humans with mild 
cognitive impairment. 
Altogether, mitochondrial DNA deletions, neuron loss, neurotransmitter decline, and 
myelin breakdown represent only a small portion of the changes that occur in the brain with age.  
It is absolutely essential to study this complex problem today: in the United States alone, the 
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number of individuals over the age of 65 is expected to nearly double by 2050 (Ortman et al., 
2014). As noted earlier, age-related diseases become more common and comorbidity increases as 
a population ages (Halaweish & Alam, 2014). In the United States, life expectancy at 65 years 
old has increased dramatically in the last 30 years, but mortality from some of the most common 
causes of death—cardiac disease and stroke—has decreased (Halaweish & Alam, 2014). Thus, 
the aging brain is quickly becoming one of the most important health issues in the United States.   
The United States is certainly not alone (Ortman et al., 2014). With only about 20% of 
the population expected to be over age 65 by 2030, the United States is actually one of the 
youngest developed countries (Ortman et al., 2014). The only developed country with less 
elderly individuals than the United States is Russia, where 13% of the population is expected to 
be over 65 by 2030 (Ortman et al., 2014). Most developed countries will have about 25% of their 
population over 65 by 2030 (Ortman et al., 2014). Japan’s population over age 65 is expected to 
be 32.2% of their population by 2030 (Ortman et al., 2014). Aging and age-related conditions are 
thus increasing in importance globally, and require extensive study to understand mechanisms 
and develop treatments.   
Aging and the Senses 
 While the brain ages and becomes less efficient, so do the sensory systems. Vision and 
audition become particularly impaired with age. According to a 2004 study, 1 in 28 Americans 
over 40 suffer from blindness or low visual ability, and that occurrence is expected to rise over 
the next several years (Eye Diseases Prevalence Research Group, 2004). Likewise, age-related 
hearing loss (ARHL) is common amongst older individuals, affecting 30% of people over 65, 
63% of people over 70, and 80% of people over 85 (Bainbridge & Wallhagen, 2014; Dubno et 
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al., 2013). In fact, it is the third most common chronic condition in the elderly population, after 
arthritis and hypertension (Li-Korotky, 2012).  
 AHRL is also associated with cognitive decline, loneliness, and depression in the elderly. 
ARHL is often comorbid with accelerated dementia and cognitive decline, as supported by 
longitudinal studies (Lin et al., 2011; Lin et al., 2013). Hearing ability is correlated with 
loneliness, particularly in men and people who do not use hearing aids (Pronk et al., 2013). The 
rate of hearing loss also plays a role; Pronk et al. (2014) found that a faster decrease in speech-
in-noise detection ability is correlated with a greater increase in both emotional and social 
loneliness. Although ARHL appears to be associated with negative affect, the link  between 
ARHL and depression is disputed. In the Longitudinal Aging Study Amsterdam (LASA), 
depression and hearing decline were independent from one another (Pronk et al., 2013; Pronk et 
al., 2014). However, other studies using multiple different longitudinal groups have shown that 
depression is comorbid with ARHL, and that use of hearing aids can alleviate depressive 
symptoms in elderly patients over time (Acar et al., 2011; Boi et al. 2012).  
In both the visual and auditory systems, research is often focused on the peripheral 
sensory organ, as opposed to the central processing system. The peripheral organs or sensory 
cells—such as the retina, cochlea, photoreceptor cells, or hair cells—have more well-defined 
functions, are more safely and easily accessible, and are thus easier to investigate. Many 
technological advances have arisen out of the study of peripheral sensory organs, including 
optogenetics and artificial retinas and cochleas (Gradinaru et al., 2010). Although the study of 
hair cells has expanded our understanding of audition, signal transduction, psychophysics, and 
biophysics, and the study of photoreceptors has increased out knowledge of vision, transduction, 
and color perception, it is also important to study the central systems.  
AHRL:	  INHIBITION	  AND	  EXCITATION	  IN	  THE	  IC	   12	  
Human studies using a comprehensive set of auditory tests reveal that the central auditory 
system indeed changes with age (Mazelová et al., 2003). Both temporal resolution and speech 
perception require central auditory system function, and thus can be used to detect changes 
(Mazelová et al., 2003). Mazelová et al. (2003) found that the ability to discern both speech and 
timing was impaired in elderly adults with ARHL, in addition to the many auditory impairments 
associated with the peripheral auditory system, such as high frequency tone loss. However, it is 
difficult to determine in humans whether these changes in the peripheral and central auditory 
systems are independent from one another (Mazelová et al., 2003). One examination of four 
human case studies that had total losses of hair cells but intact cochlear nerves—maximum 
neuron loss in the cochlear nerve was 35%—demonstrated that, in at least some instances, 
deterioration of the peripheral auditory system and deterioration of the central auditory system 
occur independently from one another (Linthicum Jr. & Fayad, 2009). Likewise, a study of 
temporal resolution in rats found that temporal resolution impairment increases with age and is 
not correlated with the degree of peripheral ARHL (Suta et al., 2011).  
One aging model, which consists of a daily overdose of the sugar D-galactose for an 
extended period, can be used to study the independent aging of the central auditory system (Du 
et al., 2012; Parthasarathy et al., 2014). The D-galactose model, used primarily for modeling 
neurodegenerative diseases and natural aging, mimics the oxidative stress and free radical 
damage seen with age (Hsieh et al., 2009). Du et al. (2012) aged the inner ear of rats with an 8-
week D-galactose regimen and a high fat diet. They found elevated levels of NADPH oxidase, 
mitochondrial DNA mutations, and caspase-3 in the inner ear cells, signs of oxidative stress, cell 
death, and aging (Du et al., 2012). However, Du et al. (2012) only examined one facet of 
functional hearing ability, the threshold of the auditory brainstem response (ABR). 
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The ABR is a frequently used measure of auditory system function and is useful in 
demonstrating the discrete aging of the central auditory system and the peripheral auditory 
system (Parthasarathy et al., 2014). The ABR threshold is indicative of peripheral auditory 
system sensitivity and typically increases during aging, indicating a decrease in sensitivity of the 
peripheral auditory system (Du et al., 2012; Parthasarathy et al., 2014; Seidman et al., 1997). 
Moreover, each of the waves is representative of activity at a certain level of the auditory system; 
for example, the amplitude of wave I, as seen in Figure 1, is positively correlated with cochlear 
nerve activity (Parthasarathy et al., 2014; Stockard & Rossiter, 1977; Engle et al., 2014). After 
wave I, the subsequent waves represent activity at a mixture of neural generators, but are 
dominated by the activity in one generator; for instance, the amplitude of wave IV is correlated 
with IC activity (Parthasarathy et al., 2014; Stockard & Rossiter, 1977; Engle et al., 2014). 
Parthasarathy et al. (2012) were the first to use two electrodes and two channels to record ABRs; 
in one-channel recordings, the sharp negative wave in channel 1, as seen in Figure 1, is 
considered wave IV. The amplitudes of the waves decrease with age, and the degree of their 
reduction is correlated with the degree of central auditory system aging (Parthasarathy et al., 
Figure	  1:	  ABR	  waveforms	  from	  young	  (3-­‐6	  months)	  and	  aged	  (22-­‐24	  months)	  Fischer-­‐344	  rats.	  Parthasarathy et al. (2012) were the first to use two electrodes to record two-channel 
ABRs. Image	  from	  Parthasarathy et al., 2014. 	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2014). Although another study found a correlation between ABR wave IV amplitude and ABR 
threshold (Engle et al., 2014), Parthasarathy et al. (2014) found that in both young and aged 
animals, the ABR thresholds are not correlated with any of the ABR amplitudes. 
In an unpublished study from the same lab, the individual ABR waves were examined in 
a D-galactose model (Parthasarathy et al., manuscript in preparation). The researchers found that 
the greatest difference between untreated rats and D-galactose treated rats was in the waveforms 
associated with highers central auditory system areas, such as the inferior colliculus (IC) and 
auditory cortex, rather than the waveforms associated with the lower, more peripheral areas, such 
as the cochlear nucleus (Parthasarathy et al., manuscript in preparation). In conjunction with 
Parthasarathy et al. (2014), the unpublished study demonstrates the disassociation and 
independence of central auditory system aging and peripheral auditory system aging. 
The central auditory system, as seen in Figure 2, begins with the auditory nerve, also 
known as the cochlear nerve, which extends from the cochlea to the cochlear nucleus (Purves et 
al., 2004). The stimulus then moves from the cochlear nucleus to the superior olive, also known 
as the known as the superior olivary complex, and from the superior olive to the lateral 
lemniscus (Purves et al., 2004). The next highest area is the IC, which receives afferent signals—
signals moving from the peripheral nervous system inwards towards the central nervous 
system—directly from the lateral lemniscus, the superior paraolivary nucleus of the superior 
olive, and the cochlear nucleus  (Purves et al., 2004; Felix II et al., 2015). The IC also receives 
efferent signals—signals moving from the central nervous system outwards towards to peripheral 
nervous system—from the auditory cortex (Feliciano & Potashner, 1995). From the IC, 
projections lead primarily to the medial geniculate body, although a few IC projections terminate 
elsewhere including the cochlear nucleus (Coomes & Schofield, 2004; Purves et al., 2004).  
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Figure	  2:	  The	  central	  auditory	  pathway.	  Image	  from	  Purves	  et	  al.,	  2004.	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Finally, the projections from the medial geniculate body lead to the auditory cortex (Purves et al., 
2004).   
All of the areas of the central auditory system are affected by aging. The decrease in 
neuron count in the central auditory system is generally believed to be minimal; studies have 
shown an insignificant decrease in the total number of neurons in the IC, auditory cortex, and 
medial geniculate body (Burianová et al., 2015). However, Burianová et al., (2015) demonstrated 
that there is a significant decrease in the number of SMI-32-immunoreactive (-ir) neurons in the 
IC, auditory cortex, and medial geniculate body. SMI-32-ir neurons only make up about 10-30% 
of total neurons in the central auditory system of a young healthy brain, but they are very 
efficient, highly myelinated, fast conducting neurons (Ouda et al., 2011). Recent research has 
shown that aging is associated with the selective loss of those most myelinated and efficient 
neurons in the auditory system, presumably causing the entire system to slow and lose efficiency 
(Burianová et al., 2015). 
Similarly, a decrease in myelination in the auditory system instigates a decrease in speed 
and efficiency. In particular, myelination of the cochlear nerve is significantly affected by aging 
(Xing et al., 2012). Xing et al. (2012) examined myelin basic proteins (MBP), proteins produced 
by oligodendrocytes and Schwann cells that make up about 30% of the myelin sheath, in both 
mice and postmortem human tissue. They discovered that myelin sheaths and Schwann cell 
cytoplasms not only deteriorate with age but also become unorganized. Much of this 
disorganization is in the form of electron dense inclusions, tightly-packed globular artifacts 
typical of aging. Often electron dense inclusions are made up of non-functional proteins and 
peptides, and in this case are likely derived from the breakdown of MBPs and other myelin-
related proteins. As expected, these disorganizational indicators were associated with a decline in 
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cochlear nerve function, as seen in the ABR (Xing et al., 2012). The number of electron dense 
inclusions was negatively correlated with ABR wave I amplitude, indicating that as the 
deterioration and disorganization increases, the functionality of the cochlear nerve decreases 
(Xing et al., 2012).  
Mitochondrial DNA deletions are also implicated in cochlear nerve aging. Seidman et al. 
(1997) recorded the ABRs of Fischer-344 rats in four age groups before sacrificing and 
examining the mitochondrial DNA in their cochlear nerves. They found that the percentage of 
animals with mitochondrial DNA deletions in their cochlear nerve cells increased from 0% in the 
individuals under 11 months of age to 28% in the individuals over 18 months of age. A more 
recent study confirmed the finding in humans, with ARHL-affected individuals possessing 260% 
more mitochondrial DNA mutations than those ARHL-unaffected individuals (Markaryan et al., 
2009).  
Like the brain as a whole, there is an age-related decrease in neurotransmitters in the 
central auditory system.  One of the most common neurotransmitters, acetylcholine, is seen to 
decrease in the central nucleus of the IC (ICc) and the lateral lemniscus of Fischer-344 rat by 24-
26 months, as measured by its rate-limiting synthesis enzyme choline acetyltransferase (ChAT) 
(Raza et al., 1994). On the other hand, levels of ChAT remain relatively stable throughout the 
lifespan in the cochlear nucleus (Raza et al., 1994). Gamma-aminobutyric acid (GABA), the 
most common inhibitory neurotransmitter, also decreases with age in the ICc, auditory cortex, 
and lateral lemniscus, as measured by its rate-limiting synthesis enzyme as glutamic acid 
decarboxylase (GAD) (Burianová et al., 2008; Raza et al., 1994). GAD levels decrease more 
quickly in the ICc than in the lateral lemniscus, with GAD levels reaching aged levels in the ICc 
by 15-17 months and in the lateral lemniscus of by 24-26 months (Burianová et al., 2008; Raza 
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et al., 1994). However, like ChAT, GAD levels do not significantly decrease in the cochlear 
nucleus across the lifespan (Raza et al., 1994). Importantly, researchers found that the GAD 
decrease in the auditory cortex is much more significant than that in the visual cortex, indicating 
that the changes in GAD and GABA levels are particularly essential to the central auditory 
system (Burianová et al., 2008).  
Much past research has shown that the peripheral auditory system changes with age, but 
the study of the age-related changes in the  central auditory system is nascent. The existing 
research illustrates only part of the full picture, and further research is necessary in order to 
determine the full extent of central auditory system aging, understand its mechanisms, and 
develop therapies.  
Aging of the Inferior Colliculus 
The focus of the current study is on aging of the central nucleus of the IC (ICc). There are 
two primary types of neurons in the IC that respond to postsynaptic depolarizations in distinctive 
ways (Peruzzi et al., 2000). Onset neurons, which make up about 30% of all IC neurons, respond 
quickly and briefly with 1-2 action potentials at the onset of a stimulus, then have a long 
depolarization with no further action potentials, and finally a relatively small amplitude 
hyperpolarization (Peruzzi et al., 2000). Sustained neurons, which make up about 70% of all IC 
neurons, come in several subset types (Peruzzi et al., 2000). However, they are generally 
characterized by repeated action potentials in response to an auditory or electrical stimulus, with 
the firing rate correlated in some way with the stimulus intensity or current (Peruzzi et al., 2000).  
Smith et al. (1999) demonstrated that subcortical regions, including the IC, are likely 
more vulnerable to aging than the cortex. However, age-related neuron loss in the IC is minimal 
(Burianová et al., 2015; Helfert et al., 1999; Ouda et al., 2011). Some studies detect no neuron 
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loss in the rat IC between age groups (Helfert et al., 1999). On the contrary, other studies 
conclude that a small number of neurons, 7% in Long-Evans rats and 9% in Fischer-344 rats, are 
lost with age (Burianová et al., 2015). In particular, there appears to be a selective loss of some 
of the most efficient IC neurons, SMI-32 neurons, as seen in the other areas of the auditory 
system (Burianová et al., 2015). SMI-32 neurons make up 9% of the total neurons in the IC of 
young rats, and the number of SMI-32 neurons in the IC decreases about 17% with age 
(Burianová et al., 2015; Ouda et al., 2011).  
 Onset and sustained neurons synapse with both inhibitory and excitatory projections to 
the IC (Peruzzi et al., 2000). As noted, the IC receives afferent projections from the lateral 
lemniscus, the superior olive, and the cochlear nucleus, as well as efferent projections from the 
auditory cortex (Purves et al., 2004; Felix II et al., 2015; Feliciano & Potashner, 1995). It 
receives both inhibitory and excitatory projections from the lateral superior olive and the 
intermediate nucleus of the lateral lemniscus (Bajo et al., 1999; Glendenning et al., 1992). 
However, inputs to the IC from the dorsal cochlear nucleus and the medial superior olive are 
exclusively excitatory (Davis, 2002; Glendenning et al.,1992; Semple and Aitkin, 1980) and 
inputs from the dorsal and ventral nuclei of the lateral lemniscus are exclusively inhibitory 
(Adams and Mugnaini, 1984; Bajo et al., 1999; Malmierca et al., 1998; Riquelme et al., 2001; 
Vater et al., 1997; Winer et al., 1995). 
Excitatory inputs to the IC synapse with dendritic spines, dendrites, and cell bodies, but 
only about 2% of excitatory synapses are axosomatic (Nakamoto et al., 2013) Excitatory 
projections synapse with both GABAergic and non-GABAergic neurons, but more often synapse 
with non-GABAergic cells (Nakamoto et al., 2013). Despite that, however, large GABAergic 
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cells in the ICc are covered in excitatory, particularly glutamatergic, synapses so that they can 
fire quickly and easily (Ouda & Syka, 2012). 
Excitatory synapses in the IC can be classified into three categories (Nakamoto et al., 
2013). Large excitatory boutons have the biggest area, most mitochondria, are found almost 
exclusively in the ICc, and are likely projections from the lateral lemniscus, otherwise known as 
lemniscal inputs to the IC (Nakamoto et al., 2013). Medium excitatory boutons have an average 
area and number of mitochondria and are found throughout IC with about 57% in the ICc 
(Nakamoto et al., 2013). It is believed that some medium excitatory boutons in the IC are 
lemniscal inputs, while others are projections from elsewhere in the ipsilateral IC or from the 
contralateral IC (Nakamoto et al., 2013). Finally, small excitatory boutons have the smallest area 
and few or no mitochondria (Nakamoto et al., 2013). They are mostly found in the external 
cortices of the IC—only 20% are found in the ICc—and are likely inputs from the auditory 
cortex, the ipsilateral IC, and the contralateral IC (Nakamoto et al., 2013).  
Inhibitory boutons in the IC are either GABAergic or glycinergic (Buentello et al., 2015).  
GABAergic terminals, as seen by GAD staining, are spread relatively homogenously throughout 
the IC, including the ICc (Buentello et al., 2015). GABA boutons are more numerous than 
glycinergic boutons throughout most of the ICc; hence, GABA is believed to be the primary 
inhibitory neurotransmitter of the ICc (Buentello et al., 2015). 
 There are two types of GABAergic neurons in the IC (Ouda & Syka, 2012). Small and 
large GABAergic neurons have different synaptic organization and project to different targets 
(Ouda & Syka, 2012). Small GABAergic neurons mainly project locally within the IC (Ouda & 
Syka, 2012). In fact, the most important source of inhibitory projections to the IC is the IC itself; 
the number of GABAergic neurons in the ICc with local projections is much higher than that in 
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all the lower brainstem auditory nuclei combined (Ouda & Syka, 2012). Large GABAergic 
neurons in the IC are located mainly in the ICc and primarily project to the medial geniculate 
body (Ouda & Syka, 2012). Because only vesicular glutamate transporter 2 (VGluT2) is present 
in the presynaptic terminals synapsing on large GABAergic neurons, it is likely that they are 
activated by glutamatergic inputs from the IC or dorsal cochlear nucleus (Ouda & Syka, 2012). 
Additionally, it is worth noting that large GABAergic neurons have very thick axons, which may 
allow the inhibitory information to reach the medial geniculate body before the excitatory 
information from the IC reaches the medial geniculate body (Ouda & Syka, 2012). 
Inhibition is particularly important in the IC, as reviewed by Pollak et al. (2011). Only 
about 30-40% of the neurons in the ICc are inhibitory (Nakamoto et al., 2013; Ouda & Syka, 
2012). However, GAD levels are three times higher in the IC than in the neocortex at all ages, 
indicating its relative importance to the IC (Ouda & Syka, 2012). Inhibition, and particularly 
GABA, is also very important to IC function (Felix II et al., 2015; LeBeau et al., 2001; Palombi 
& Caspary, 1996; Pollak et al., 2011). For instance, inactivating the inhibitory projections from 
the superior periolivary complex in the superior olive to the IC causes a significant decrease in 
temporal resolution in both onset and sustained neurons in the IC (Felix II et al., 2015). 
Additionally, sideband inhibition serves as an excellent example of the importance of dominance 
in the IC (Pollak et al., 2011). Individual IC neurons respond to a specific range of frequencies, 
including a target frequency, which always induces the firing of action potentials, and flanking 
frequencies, which trigger lower but still suprathreshold depolarizations (LeBeau et al., 2001; 
Palombi & Caspary, 1996). Inhibitory signals decrease the depolarizations triggered by flanking 
frequencies and stop them from producing action potentials; thus IC inhibition decreases the size 
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of neurons’ tuning curve and increases neurons’ specificity (LeBeau et al., 2001; Palombi & 
Caspary, 1996).  
Because inhibition is believed to be the dominant signal in the IC, most research on the 
aging of the IC has focused on GABA (Nakamoto et al., 2013; Pollak et al., 2011). A number of 
studies have shown that GABA-mediated inhibition in the IC decreases with age (Helfert et al., 
1999; Ouda & Syka, 2012). There is a significant decrease in the number of GAD-ir neurons 
throughout the IC with age (Ouda & Syka, 2012). Western Blot confirmed the 
immunohistochemical findings and demonstrated a decrease of 50% in IC levels of GAD 
between young and old rats (Ouda & Syka, 2012). Likewise, in both Fischer-344 and Sprague-
Dawley rats, binding intensity of both subtypes of GABA receptors significantly decreases with 
age, as does the concentration of the receptor subunits in the IC (Ouda & Syka, 2012). The 
decreases in GAD may indicate a decrease in enzymatic activity, a decrease in GABA levels, or 
a decrease in the release or function of GABA (Ouda & Syka, 2012). However, it is clear that 
something about the production, release, or functionality of GABA in the IC changes with age.  
Although there is a multitude of research on GABA and inhibition in the IC with aging, 
there is a dearth of research on excitation in the IC with aging. In the current study, the role of 
glutamate in the aging IC is examined. Only one major study specifically examined age-related 
glutamate changes in the IC (Tadros et al., 2007). Tadros et al. (2007) assessed the mRNA levels 
of 68 glutamate-related genes in the IC of CBA/CaJ mice and related the gene expression with 
ABR recordings. The five genes that demonstrated the greatest changes in expression with age 
through a gene expression microarray were the gene for VGluT2 (Slc17a6), the genes for two 
other high-affinity glutamate transporters (Slc1a2 and Slc1a3), the gene for pyrroline-5-
carboxylate synthetase (Pycs), and the gene for glutamate receptor inotropic kainate 3 (Grik3) 
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(Tadros et al., 2007). Only Pycs and Slcla3 also demonstrated large changes in expression using 
real-time PCR (Tadros et al., 2007). Pycs expression alone was correlated with ABR thresholds; 
ABR wave amplitudes were not examined (Tadros et al., 2007). Because pyrroline-5-carboxylate 
synthetase helps convert glutamate to proline, the researchers hypothesized that a decrease in 
Pycs expression may actually indicate that glutamate levels increase with age, while proline 
levels decrease (Tadros et al., 2007). A major weakness of the study conducted by Tadros et al. 
(2007) was that they examined gene expression and not protein expression; it is possible that the 
glutamate-related gene expression is not reflective of glutamate-related protein expression. 
However, the study does indicate that there are likely some changes in glutamate-related protein 
expression and glutamate functionality in the IC with age. 
The current study aims to better understand age-related changes to IC glutamate levels 
and to elucidate the relationship between GABA and glutamate in the aging IC. GABA and 
glutamate signaling interact in the IC in subtle ways (Casseday et al., 2000; LeBeau et al., 2001; 
Palombi & Caspary, 1996). Sideband inhibition, as explained above, is one instance in which 
excitatory and inhibitory events in the IC interact to shape function (LeBeau et al., 2001; 
Palombi & Caspary, 1996). Further, Casseday et al. (2000) found that in big brown bats, 
inhibitory and excitatory events in the IC are temporally linked and jointly encode sound 
duration information. They found that inhibitory and excitatory events were temporally offset 
from one another; both were correlated with the onset, inhibition was correlated with the 
duration, and excitation was correlated with the offset (Casseday et al., 2000).  
Only one previous study has attempted to assess the IC inhibition—excitation 
relationship during aging (Helfert et al., 1999). Helfert et al. (1999) quantified the age-related 
changes in GABA-ir (GABA+) and GABA-immunonegative (GABA-) synapses. Comparing 3-
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month-old rats to 28-month-old rats, the researchers found similar decreases in synapse density 
for both GABA+ and GABA- synapses, about 30% and 24% respectively (Helfert et al., 1999). 
The researchers hypothesized that the decrease was due primarily to the loss low diameter 
(caliber) dendrites; they found that there was a significant decrease in the number of dendrites 
with calibers between 0.5 and 1.5 µm and that the number of high caliber GABA+ and GABA- 
dendrites did not change significantly with age (Helfert et al., 1999). Although this study’s 
analysis of synapses is informative, its lack of staining for a specific neurotransmitter other than 
GABA is a major weakness. The researchers claim that the GABA- synapses are excitatory; 
however, there is no way to tell which excitatory neurotransmitter the synapses contain or even 
whether or not the synapses contain a different inhibitory neurotransmitter (Helfert et al., 1999). 
Changes in the inhibition—excitation balance have been implicated in age-related 
function decreases in other brain areas (Legon et al., 2015). Thus, it is important to understand 
the relationship in age-related hearing loss, particularly in the IC where the relationship between 
inhibition and excitation is vitally important to function (Casseday et al., 2000; LeBeau et al., 
2001; Palombi & Caspary, 1996). The objective of this study was to examine the relationship 
between inhibition and excitation, particularly GABA and glutamate, in ICc aging. Additionally, 
the study was intended to provide novel data on the age-related changes in glutamatergic 
function in the ICc, as illustrated by VGluT2. We expected to find a decrease in VGluT2, as well 
as a decrease in GAD67. However, we also expected the ratio between the two to shift because 
GAD67 expression decreased more with age than VGluT2 expression. Finally, we anticipated 
that the ABR wave IV amplitude would be more highly correlated and a better predictor of 
GAD67 levels, VGluT2 levels, and the GAD67: VGluT2 ratio than ABR thresholds, indicating a 
separation between central auditory system aging and peripheral auditory system aging.  
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Methods 
Subjects 
Eight male Fischer-344 rats were used in the study. Fischer-344 rats are appropriate 
because they are known for their rapid aging, used in many aging studies, and recognized as a 
good model for presbycusis (Burianová et al., 2015; Syka, 2010). The four young rats had a 
mean age of 5 months (SD = 0.4 months) and a mean weight of 403.75 grams (SD = 36.63 
grams). The four aged rats had a mean age of 22.5 months (SD = 1.7 months) and a mean weight 
of 420.72 grams (SD = 29.95 grams). All procedures followed those set out by the Purdue 
Animal Care and Use Committee (PACUC) and researchers were trained by the PACUC in the 
ethical handling and use of animals.  
Auditory Brainstem Response 
 We anesthetized rats using 4% isoflurane gas in a closed chamber. After checking the 
level of anesthesia using a toe pinch, we moved the rats from the chamber to a manifold in a 9’ x 
9’ double walled acoustic chamber (Industrial Acoustics Corporation). We placed a water 
circulating warming blanket (Gaymar) set to 37ºC under the animals and inserted subdermal 
needle electrodes (Ambu). The locations of the channel 1 and 2 electrodes are indicated in Figure 
3, with channel 1 along the sagittal line of the 
skull in front of the ears and channel 2 along the 
interaural line. We inserted the negative electrode 
directly under the mastoid and the ground 
electrode in the nape of the neck. We then 
intramuscularly injected 0.1-0.2 mg/Kg of 
dexmedetomidine (Dexdomitor), an α-adrenergic 
Ch.	  2	   Ch.	  1	  
Figure	  3:	  Top	  view	  of	  electrode	  locations	  on	  the	  rat	  skull	  for	  ABR	  collection	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agonist known not to affect audition (Ter-Mikaelian et al., 2007). ABR testing commenced after 
we waited 10 minutes for the isoflurane to leave the rat’s system, because isoflurane’s 
interference with GABA receptors could alter audition (Hemmings et al., 2005). We used 
SIGGenRP software to generate auditory signals and BioSig software to present stimuli and 
record responses (Tucker Davis Technologies). We performed two separate ABR recordings, one 
using brief broadband click stimuli and one using tone stimuli at 8000 Hz; each was presented in 
2 millisecond durations and varying in sound levels from 95 to 5 dB SPL in 5-10 dB steps. We 
calculated thresholds in 5 dB steps and measured the amplitude of wave IV in channel 2 at 30 dB 
sensation level, or 30 dB above the individual rat’s threshold. In the same session, we presented 
and recorded several other auditory tests, in order to minimize the number of animals needed for 
research. The results from the other auditory tests will be published in separate reports.  
Perfusion and Sectioning 
We sacrificed animals using an overdose of euthanasia solution (390 mg/mL 
pentobarbital sodium and 50 mg/mL phenytoin sodium; Euthasol). Once an animal reached a 
sufficient level of anesthetization, we conducted perfusion fixation using phosphate buffered 
saline (PBS), paraformaldehyde, and standard perfusion fixation procedures. We removed the 
brains from the skulls and froze them in optimal cutting temperature (OCT) compound at -25°C. 
We then sectioned the brains using a freezing microtome. Employing The Rat Brain atlas to 
identify its location, we collected 35 µm slices of the inferior colliculus, moving from 9.06 µm 
behind bregma to 8.46 µm behind bregma (Paxinos & Watson, 2007).  
Selection of Antibodies 
We decided to use antibodies against GAD67 and VGluT2 to examine the GABA and 
glutamate levels. GAD, as the rate-limiting enzyme for GABA’s production, is the best protein 
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to target in order to examine GABA (Burianová et al., 2008; Esclapez et al., 1994). While 
GAD65 and GAD67 may serve slightly different functional purposes, previous studies have 
found that most GABAergic neurons use both, that the two isoforms have similar distributions 
across the ICc, and that both isoforms decrease during aging (Burianová et al., 2008; Esclapez et 
al., 1994). Thus staining for either GAD isoform is acceptable.  
We chose VGluT2, as opposed to other glutamate-related proteins, for several reasons. 
Glutamate is the principal excitatory neurotransmitter of the central nervous system and was 
hence the obvious choice of excitatory neurotransmitter to compare with GABA (Meldrum, 
2000). VGluT is essential to the glutamate release process because it moves glutamate into 
synaptic vesicles and regulates the concentration of glutamate inside vesicles (Altschuler et al., 
2008; Johnson et al., 2003). Of all the isoforms, VGluT2 was most appropriate for the current 
study. VGluT1 and VGluT2 both colocalize with glutamatergic terminals, confirming they are 
involved in glutamate release; VGluT3 is actually associated with other neurotransmitters 
(Altschuler et al., 2008). VGluT1 and VGluT2 are not colocalized (Altschuler et al., 2008). 
VGluT2 is more plentiful than VGluT1 in all regions of the IC (Altschuler et al., 2008). VGluT2-
ir terminals are larger on average than VGluT1-ir terminals (Altschuler et al., 2008). VGluT2 is 
the primary VGluT in two of the three major types of synapses, axo-somatic and axo-dendritic 
synapses; VGluT1 is dominant only in axo-dendritic synapses (Altschuler et al., 2008). Finally, 
IC expression of the VGluT2 gene changes with age, indicating that VGluT2 is implicated in the 
age-related changes in the IC (Tadros et al., 2007). 
Immunofluorescent Staining 
We processed the neural tissue immediately after sectioning by progressing through a 
series of washes. Every other slice underwent secondary immunofluorescent staining for VGluT2 
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and GAD67; the other half of the slices underwent Nissl staining for another project. We 
processed tissue in pairs of animals, one young and one aged, in order to ensure differences in 
staining did not cause differences to appear between the age groups. However, we were blind to 
the ages of the animals while sectioning and staining.  
We conducted secondary immunofluorescent staining for GAD67 and VGluT2. 
Secondary, or indirect, immunofluorescence is different from primary, or direct, 
immunofluorescence in that the fluorescent molecule is attached to a secondary antibody 
(Vancells). The primary antibody, 
which lacks a fluorophore, targets the 
protein of interest (Vancells). The 
secondary antibody, with the attached 
fluorophore, targets the primary 
antibody (Vancells). The confocal 
microscope’s laser excites the 
fluorophore on the secondary antibody 
(Vancells). We utilized secondary immunofluorescence because it allows for an amplification of 
the fluorescence, making the staining easier to detect (Vancells). Figure 4 shows the mechanisms 
of secondary immunofluorescence; a full protocol can be found in Appendix B. Tissue from a 
total of six rats (3 young, 3 aged) underwent staining for both GAD67 and VGluT2. Tissue from 
two rats (1 young, 1 aged) was stained only for GAD67. For each animal, we performed two 
negative controls during staining: one containing only the primary antibody and one containing 
only the secondary antibody.  
 
Protein	  of	  Interest	  Primary	  Antibody	  Secondary	  Antibody	  Fluorophore	  
Figure	  4:	  Components	  and	  mechanism	  of	  secondary	  immunofluorescent	  staining	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Confocal Microscopy and Image Analysis 
We captured z-stack images using an inverted Zeiss LSM 710 confocal microscope with 
a 63x oil lens. For each slice, we imaged both the lateral and dorsal sides of the IC central 
nucleus; The Rat Brain atlas was used to define the boundaries of the central nucleus (Paxinos & 
Watson, 2007). Image analysis was performed using ImageJ software. To ensure that the images 
were from the middle of the section, we analyzed the middle image of the z-stack (5 µm steps). 
We were blind to the age of the animal while capturing and analyzing the confocal images. For 
staining intensity measurements, we calculated the background intensity by selecting five widely 
distributed low brightness areas in each image, finding their mean intensity, and averaging the 
five means. We then subtracted the background intensity for a given image from all the 
individual terminal staining intensity measurements for that image. Additionally, we imaged and 
analyzed the negative controls to ensure there was not excessive background staining. The 
minimum terminal area included in the study was 0.1 μm2; the maximum was 8.083 μm2.  
Logarithmic Transform and Statistical Analysis 
Because data for staining intensity and terminal area were both positively skewed, we 
performed a logarithmic transform (Log10) using the IBM SPSS Statistics Data Editor 23 
(SPSS). Figure 5 shows an example of data before and after the logarithmic transform. Further, 
all data for terminals with untransformed areas over 1.602 µm2 were considered outliers and 
moved to a separate file for analysis in a later paper. Unless otherwise indicated, we performed 
all statistics using the data points for individual terminals in individual images of the ICc. For the 
ratio calculations, we used the median of the untransformed terminal area and terminal staining 
intensity distributions for individual images. All other results and figures use the logarithmically 
transformed data. We ran descriptive statistics, correlations, and multiple regression analyses 
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with interaction terms in SPSS. We considered P-values of 0.05 or less as significant. We created 
our figures using SPSS and Microsoft Word.  
  
Figure	  5:	  An	  example	  of	  the	  logarithmic	  transform.	  (A)	  shows	  the	  data	  for	  the	  VGluT2	  staining	  intensity	  in	  all	  aged	  subjects	  before	  the	  transform.	  (B)	  shows	  the	  data	  after	  the	  Log10	  transform.	  	  




B:	  Log-­‐Transformed	  VGluT2	  	  Staining	  Intensity	  in	  Aged	  Rats	  
Log10	  Staining	  Intensity	  
Freque
ncy	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Results 
ICc Region  
 We performed Pearson product-moment correlations to determine whether ICc region, 
dorsal or ventral, was correlated with terminal area or staining intensity. The IC is typically 
divided into three areas: the central nucleus (ICc), the dorsal cortex (ICd), and the external cortex 
(ICe) (Ouda & Syka, 2012). The central cortex itself is tonotopically organized and can thus be 
divided further into the dorsal section of the ICc (ICcd), which responds to lower frequency 
tones, and the ventral section of the ICc (ICcv), which responds to higher frequency tones 
(Clopton & Winfield, 1973). The 
individual cells in these regions 
respond to specific characteristic 
frequencies and a limited range 
around that frequency (Clopton & 
Winfield, 1973). Figure 6 shows all 
of the IC regions.  
Because high frequency 
hearing loss usually occurs before 
low frequency hearing loss, it is 
plausible that there would be 
greater age-related changes to the ICcv than to the ICcd (Ng et al., 2015). However, we found no 
significant correlation or a significant correlation of negligible size between ICc region and both 
terminal area and staining intensity; see Figure 7 for more information. 
ICd	  
ICcd	  	  	  
ICc	  	  	  ICcv	  
ICe	  
Figure	  6:	  Regions	  of	  the	  inferior	  colliculus,	  at	  8.88	  µm	  behind	  bregma.	  Image	  adapted	  from	  Paxinos	  &	  Watson,	  2007.	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Location Along the Sagittal Axis 
Additionally, it is possible that the distance from bregma, which is often used to 
determine location along the anterior-posterior or sagittal axis of the brain, could be correlated 
with the staining intensity or terminal area (Paxinos & Watson, 2007). Figure 8 shows bregma on 
the rat skull and the location of bregma in relation to the rat brain. Pearson correlation revealed 
no significant relationship or a significant relationship of negligible size between bregma and 
both terminal area and staining intensity, with one notable exception. The variables bregma and 
VGluT2 staining intensity were weakly negatively correlated in aged animals, r(13511) = -.249, 
p = .000, as seen in Figure 9. This significant weak correlation may indicate that there is anterior-
posterior organization of glutamatergic synapses; specifically that glutamate levels are higher in 
posterior slices than in anterior slices. Nevertheless, anterior-posterior organization of the ICc is 
GAD67	   	   	   	   VGluT2	  





Figure	  7:	  The	  correlations	  between	  ICc	  region	  and	  staining	  intensity	  or	  terminal	  area	  were	  significant	  but	  of	  a	  very	  small	  magnitude,	  with	  one	  nonsignificant	  exception.	  Significant	  correlations	  (p	  <	  0.05)	  are	  shown	  in	  color	  and	  nonsignificant	  correlations	  are	  shown	  in	  grayscale.	  The	  two	  largest	  magnitude	  significant	  correlations	  were	  between	  ICc	  region	  and	  VGluT2	  staining	  intensity	  in	  aged	  animals,	  r(13511)	  =	  -­‐.188,	  p	  =	  .000,	  and	  between	  ICc	  region	  and	  VGluT2	  staining	  intensity	  in	  young	  animals,	  r(19951)	  =	  -­‐.096,	  p	  =	  .000.	  All	  other	  magnitudes	  were	  less	  than	  r	  =	  |.03|.	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not the focus of the current study and the correlation is weak; consequently, location along the 




    
Figure	  8:	  Location	  of	  bregma	  on	  the	  skull	  and	  brain.	  (A)	  shows	  the	  location	  of	  bregma	  on	  the	  skull	  itself.	  (B)	  shows	  the	  relative	  location	  of	  bregma	  to	  the	  brain	  areas,	  including	  the	  inferior	  colliculus.	  Image	  from	  Paxinos	  &	  Watson,	  2007.	  	  
A	  
B	  
AHRL:	  INHIBITION	  AND	  EXCITATION	  IN	  THE	  IC	   34	  
 
Auditory Function 
Previous studies disagree as to whether ABR thresholds are correlated with the 
amplitudes of specific waves in the ABR. We found a very strong negative correlation between 
click ABR threshold (M = 36.2 dB, SD = 2.5) and click ABR wave IV amplitude (M = 2.13 µv, 
SD = .95) in young animals, r(4) = -.986, p = .014, but no correlation between the click ABR 
threshold (M = 52.5 dB, SD = 11.9) and click ABR wave IV amplitude (M = 1.26, SD = .37) in 
aged animals, r(4) = -.404, p = .595. There was no correlation between click ABR wave IV 
amplitude and tone ABR threshold in young animals  (M = 27.5 dB, SD = 2.89), r(4) = -.478, p = 
.522, or aged animals (M = 38.75 dB, SD = 4.79), r(4) = .049, p = .951. Finally, there was no 
correlation between click ABR threshold and tone ABR threshold in young animals, r(4) = .577, 
p = .423, or aged animals, r(4) = -.073, p = .927. 
GAD67	   	   	   	   VGluT2	  





Figure	  0:	  The	  correlations	  between	  sagittal	  location	  and	  staining	  intensity	  or	  terminal	  area	  were	  significant	  but	  of	  a	  very	  small	  magnitude,	  with	  one	  nonsignificant	  exception.	  Significant	  correlations	  (p	  <	  0.05)	  are	  shown	  in	  color	  and	  nonsignificant	  correlations	  are	  shown	  in	  grayscale.	  The	  three	  largest	  magnitude	  significant	  correlations	  were	  between	  sagittal	  location	  and	  VGluT2	  staining	  intensity	  in	  aged	  animals,	  r(13511)	  =	  -­‐.249,	  p	  =	  .000,	  between	  sagittal	  location	  and	  GAD67	  staining	  intensity	  in	  young	  animals,	  r(23909)	  =	  .164,	  p	  =	  .000,	  and	  between	  sagittal	  location	  and	  GAD67	  staining	  intensity	  in	  aged	  animals,	  
r(18613)	  =	  -­‐.106,	  p	  =	  .000.	  All	  other	  magnitudes	  were	  less	  than	  r	  =	  |.03|.	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Age was strongly positively correlated with both click ABR threshold, r(8) = .737, p = 
.037, and tone ABR threshold, r(8) = .854, p = .007, but not click ABR wave IV amplitude, r(8) 
= -.569, p = .141. This indicates that threshold for both ABRs was much higher in aged animals 
than in young animals, but that click ABR wave IV amplitude was not significantly different in 
young and aged animals. 
GAD67-ir Presynaptic Terminals  
Figure 10 contains histograms of GAD67-ir terminal area in young and aged rats. The 
average of non-transformed GAD67-ir terminal area was 0.341 µm2 (SD = .272) in young 
animals and 0.335 µm2 (SD = .266) in aged animals. There is an extremely weak negative 
correlation between age and GAD67-ir terminal area, r(41907) = -.01, p = .043.  
We performed a multiple regression analysis to determine if GAD67-ir terminal area 
could be predicted by age and the functional auditory measures, tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude. A full interaction model was used. The model is 
significant, but only weakly predicts terminal area. The variables with the strongest independent 
contributions to the model were age, tone ABR threshold, and click ABR wave IV amplitude. 
Additionally, there was an important interaction effect between tone ABR threshold and click 
ABR wave IV amplitude. The full results can be seen in Table 1. 
Figure 11 contains histograms of GAD67-ir terminal optical density in young and aged 
rats. The average of non-transformed GAD67-ir terminal optical density was 150.08 (SD = 
49.90) in young animals and 138.00 (SD = 62.24) in aged animals. There is a weak but 
significant negative correlation between age and GAD67-ir terminal optical density, r(41907) = -
.156, p = .000. This finding indicates that as age increases, optical density decreases slightly, as 
seen in Figure 12. We also found that there is a significant positive correlation between area and  
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Table 1 
Summary of Multivariate Regression Analysis for Variables Predicting GAD67 Terminal Area 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age .035 .007 .060** .512 .030 .873** 
Click amp. -.034 .003 -.093** -.481 .030 -1.302** 
Click thresh. -.009 .001 -.069** -.167 .011 -1.263** 
Tone thresh. -.019 .002 -.083** -.697 .042 -3.018** 
Tone thresh. × click thresh.    .067 .004 2.160** 
Tone thresh. × click amp.    .252 .016 1.446** 
Click thresh. × click amp.    -.082 .004 -.633** 
R2  .01   .015  
F for changes in R2  55.787**   149.276**  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 









B:	  GAD67-­‐ir	  Terminal	  Area	  in	  Aged	  Rats	  
Figure	  10:	  Histograms	  describing	  the	  logarithmically	  transformed	  distribution	  of	  sizes	  of	  GAD67-­‐ir	  presynaptic	  terminals	  in	  (A)	  young	  rats	  and	  (B)	  aged	  rats	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intensity for GAD67-ir terminals, r(41907) = .226, p = .000. Larger terminals contain more 
GAD67 than smaller terminals.  
We performed a second multiple regression analysis to determine if GAD67-ir staining 
intensity could be predicted by age and the functional auditory measures, tone ABR threshold, 
click ABR threshold, and click ABR wave IV amplitude. A full interaction model was used. The 
model strongly predicts GAD67-ir staining intensity; the interaction terms increase the strength 
of the model only slightly. The variables with the largest independent effects were age, tone 
ABR threshold, and click ABR wave IV amplitude. Additionally, there were important 
interaction effects between tone ABR threshold and click ABR wave IV amplitude and between 










B:	  GAD67-­‐ir	  Terminal	  Staining	  Intensity	  in	  Aged	  Rats	  
Figure	  11:	  Histograms	  describing	  the	  logarithmically	  transformed	  distribution	  of	  staining	  intensities	  of	  GAD67-­‐ir	  presynaptic	  terminals	  in	  (A)	  young	  rats	  and	  (B)	  aged	  rats	  




Summary of Multivariate Regression Analysis for Variables Predicting GAD67 Staining Intensity 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age .375 .003 .959** .984 .014 2.517** 
Click amp. -.129 .001 -.523** -.693 .014 -2.810** 
Click thresh. -.043 .001 -.492** -.216 .005 -2.457** 
Tone thresh. -.187 .001 -1.211** -1.075 .020 -6.967** 
Tone thresh. × click thresh.    .085 .002 4.107** 
Tone thresh. × click amp.    .341 .007 2.929** 
Click thresh. × click amp.    -.126 .002 -1.466** 
R2  .459   .519  
F for changes in R2  8872.57**   1762.17**  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 
*p < .05. **p < .01. 
Figure	  12:	  GAD67	  staining	  intensity	  is	  higher	  in	  ICc	  slices	  from	  (A)	  young	  animals	  than	  in	  ICc	  slices	  from	  (B)	  aged	  animals	  
A:	  GAD67	  Staining	  Intensity	  in	  Young	  Rats	   B:	  GAD67	  Staining	  Intensity	  in	  Aged	  Rats	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VGluT2-ir Presynaptic Terminals  
Figure 13 contains histograms of VGluT2-ir terminal area in young and aged rats. For the 
ratio calculations, we used the median of the untransformed terminal area and terminal staining 
intensity distributions for individual images. The average of non-transformed VGluT2-ir 
terminal area was 0.33 µm2 (SD = .26) in young animals and 0.32 µm2 (SD = .26) in aged 
animals. The relationship between between age and VGluT2-ir terminal area was not significant, 
r(33075) = -.01, p = .076.  
 We conducted a multiple regression analysis to determine if VGluT2-ir terminal area 
could be predicted by age and the functional auditory measures, tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude. A full interaction model was used. The model is 
significant, but only weakly predicts terminal area. Adding the interactions did not increase the 
model’s fit. The single variable with a relatively large significant independent effect to the model 
was age. Two of the three auditory functions had significant independent effects, but their 
contributions were very small. The full results can be seen in Table 3.  
Figure 14 contains histograms of VGluT2-ir staining intensity in young and aged rats. 
The average of non-transformed VGluT2-ir terminal area was 122.07 (SD = 35.34) in young 
animals and 102.95 (SD = 43.15) in aged animals. There is a weak but significant negative 
correlation between age and VGluT2-ir terminal optical density, r(33075) = -.295, p = .000. Like 
GAD67, this finding indicates that as age increases, optical density decreases, as seen in Figure 
15. We also found that there is a significant positive correlation between area and intensity for 
VGluT2-ir terminals, r(33075) = .282, p = .000. Larger terminals contain more VGluT2 than 
smaller terminals.  
 





Summary of Multivariate Regression Analysis for Variables Predicting VGluT2 Terminal Area 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age .159 .007 .275** .167 .010 .290** 
Click amp. .004 .003 .011 -.004 .007 -.013 
Click thresh. -.007 .001 -.055** -.013 .005 -.101** 
Tone thresh. -.061 .002 -.276** -.065 .004 -.294** 
Click thresh. × click amp.    .006 .004 -.037 
R2  .02   .005  
F for changes in R2  172.180**   1.478  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 






Area	   Area	  
A:	  VGluT2-­‐ir	  Terminal	  Area	  in	  Young	  Rats	   B:	  VGluT2-­‐ir	  Terminal	  Area	  in	  Aged	  Rats	  
Figure	  13:	  Histograms	  describing	  the	  logarithmically	  transformed	  distribution	  of	  sizes	  of	  VGluT2-­‐ir	  presynaptic	  terminals	  in	  (A)	  young	  rats	  and	  (B)	  aged	  rats	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We performed anther multiple regression analysis to determine if VGluT2-ir terminal 
staining intensity could be predicted by age and the functional auditory measures, tone ABR 
threshold, click ABR threshold, and click ABR wave IV amplitude. A full interaction model was 
used. The model strongly predicts VGluT2-ir terminal staining intensity, and the interaction 
terms add only marginally to the strength of the model. The variables with the largest 
independent effects were age and tone ABR threshold. None of the interactions had major 
contributions. The full results can be seen in Table 4.  





Intensity	   Intensity	  
A:	  VGluT2-­‐ir	  Terminal	  Staining	  Intensity	  in	  Young	  Rats	   B:	  VGluT2-­‐ir	  Terminal	  Staining	  Intensity	  in	  Aged	  Rats	  





Summary of Multivariate Regression Analysis for Variables Predicting VGluT2 Staining Intensity 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age .345 .003 1.091** .388 .004 1.226** 
Click amp. -.028 .001 -.144** -.070 .003 -.362** 
Click thresh. -.044 .000 -.615** -.074 .002 -1.045** 
Tone thresh. -.143 .001 -1.182** -.165 .002 -1.358** 
Click thresh. × click amp.    .031 .002 -.346** 
R2  .546   .550  
F for changes in R2  9932.893**   284.284**  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 
*p < .05. **p < .01. 
A:	  VGluT2	  Staining	  Intensity	  in	  Young	  Rats	   B:	  VGluT2	  Staining	  Intensity	  in	  Aged	  Rats	  
Figure	  15:	  VGluT2	  staining	  intensity	  is	  higher	  in	  ICc	  slices	  from	  (A)	  young	  animals	  than	  in	  ICc	  slices	  from	  (B)	  aged	  animals	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GAD67: VGluT2 Ratio 
 Figures 16 and 17 illustrate the 
relationship between GAD67-ir and VGluT2-ir 
terminals in aged and young rats. As can be seen 
in Figure 18, GAD67-ir terminals and VGluT2-
ir terminals were not colocalized. We found no 
significant correlation between age and the ratio 
for terminal area (young M = 1.078, SD = .08; 
aged M = 1.086, SD = .09), r(28) = .05, p = 
.802, or the ratio for terminal staining intensity 
(young M = 1.254, SD = .20; aged M = 1.311, SD = .39), r(28) = .097, p = .623. Likewise, there 
were no significant correlations between the ratio for terminal area and either click, r(28) = .231, 
p = .237, or tone ABR threshold, r(28) = .315, p = .103, or between the ratio for terminal staining 
intensity and either click, r(28)  = .285, p = .142, or tone ABR threshold, r(28) = -.150, p = .445. 
However, there were significant negative moderately-sized correlations between click 
ABR wave IV amplitude and the ratios for both terminal area, r(28) = -.386, p = .043, and 
terminal staining intensity, r(28) = -.411, p = .030. These findings indicate that as the amplitude 
of wave IV decreases, the GAD67: VGluT2 ratio for terminal area increases and the GAD67: 
VGluT2 ratio for terminal staining intensity decreases. The ratio for terminal area and the ratio 
for terminal staining intensity were not significantly correlated, r(28) = -.040, p = .838. 
 We conducted a multiple regression analysis to determine if the ratio for terminal size 
could be predicted by age and the functional auditory measures, tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude. A full interaction model was used. The model  
Figure	  18:	  GAD67	  and	  VGluT2	  stained	  terminals	  in	  the	  ICc	  are	  not	  colocalized.	  	  
GAD67 / VGluT2 




Figure	  X:	  Boxplot	  showing	  the	  relationship	  between	  the	  terminal	  area	  of	  GAD67-­‐ir	  and	  VGluT2-­‐ir	  terminals	  in	  young	  and	  aged	  rats	  
Intensi
ty	  
Terminal	  Staining	  Intensity	  
Figure	  X:	  Boxplot	  showing	  the	  relationship	  between	  the	  terminal	  staining	  intensity	  of	  GAD67-­‐ir	  and	  VGluT2-­‐ir	  terminals	  in	  young	  and	  aged	  rats	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strongly predicts the ratio; the interaction terms do not add significantly to the strength of the 
model. The variable with the largest independent effect was age. The full results can be seen in 
Table 5. 
 We conducted a final multiple regression analysis to determine if the ratio for terminal 
staining intensity could be predicted by age and the functional auditory measures, tone ABR 
threshold, click ABR threshold, and click ABR wave IV amplitude. A full interaction model was 
used. The model strongly predicts the ratio; the interaction terms do not add significantly to the 
strength of the model. The variables with the largest independent effects were age and tone ABR 
threshold. The full results can be seen in Table 6. 
  
Table 5 
Summary of Multivariate Regression Analysis for Variables Predicting the GAD67:VGluT2 
ratio for Terminal Area 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age -.205 .056 -1.239** -.177 .080 -1.072* 
Click amp. -.044 .020 -.423* -.070 .057 -.674 
Click thresh. .005 .008 .130 -.015 .041 -.389 
Tone thresh. .068 .019 1.114** .054 .057 -.674 
Click thresh. × click amp.    .019 .039 .462 
R2  .482   .488  
F for changes in R2  5.631**   .237  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 
*p < .05. **p < .01. 
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Table 6 
Summary of Multivariate Regression Analysis for Variables Predicting the GAD67:VGluT2 ratio 
for Staining Intensity 
 
  Model 1   Model 2  
Variable B SE B ß B SE B ß 
Age .366 .197 .629 .080 .271 .137 
Click amp. -.161 .070 -.444* .108 .193 .298 
Click thresh. .034 .030 .256 .237 .139 1.789 
Tone thresh. -.231 .067 -1.076** -.085 .118 -.394 
Click thresh. × click amp.    -.199 .133 -1.364 
R2  .479   .527  
F for changes in R2  5.276**   2.233  
Note: Tone thresh., click thresh., and click amp. represent tone ABR threshold, click ABR 
threshold, and click ABR wave IV amplitude respectively. 
*p < .05. **p < .01. 
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Discussion 
 The primary objective of this study was to examine for the first time the age-related 
changes in the inhibition—excitation relationship in the central nucleus of the inferior colliculus. 
To do so, we surveyed the characteristics of GABAergic and glutamatergic presynaptic terminals 
in the ICc using immunofluorescent staining targeting GAD67 and VGluT2. We specifically 
assessed staining intensity and terminal size—otherwise known as optical density and bouton 
size. This method of analysis is relatively novel, as many other studies examine terminal count or 
neuron count instead (Engle et al., 2014; Merchán et al., 2005; Nakamoto et al., 2013). Staining 
intensity is important because it is representative of the local concentration of the protein of 
interest (Mausset-Bonnefont et al., 2003; Merchán et al., 2005). Bouton size is critical because 
larger boutons have greater physiological strength and elicit greater postsynaptic responses by 
the ultrastructural size principle (Pierce & Lewin, 1994). The ultrastructural size principle states 
that larger boutons can have more active zones and contain more vesicles and mitochondria due 
to their larger surface area and volume; thus when stimulated, they use their greater resources to 
provoke greater effects on postsynaptic cells (Pierce & Lewin, 1994). The current study 
supported the ultrastructural size principle in that for both stains, staining intensity and bouton 
size were positively correlated, indicating that larger terminals contain more molecular 
machinery for producing and packaging neurotransmitters, and presumably elicit larger 
responses when stimulated.  
 There were four hypotheses. First, we expected that GAD67 levels in the IC would 
decrease with age, consistent with previous studies that found age-related decreases in IC 
inhibition  (Helfert et al., 1999; Nakamoto et al., 2013; Ouda & Syka, 2012; Pollak et al., 2011). 
Second, we expected VGluT2 levels in the IC to decrease with age, which has never been shown 
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before. Third, we expected the balance between inhibition and excitation in the IC to be lost with 
age. Finally, we expected that click ABR wave IV amplitude would be more highly correlated 
and a better predictor of GAD67 levels, VGluT2 levels, and the ratio between them than either 
ABR threshold because click ABR wave IV amplitude measures central auditory system function 
(Parthasarathy et al., 2014; Stockard & Rossiter, 1977; Engle et al., 2014). We address the results 
relative to each of these hypotheses in the following sections.  
Aging and GABAergic Terminals 
The findings for GAD67-ir boutons in the current study support a multitude of previous 
work that shows that GABA in the IC decreases with age (Burianová et al., 2008; Esclapez et al., 
1994). We found that GAD67-ir terminal staining intensity was very well predicted by age and 
the functional hearing measures, especially tone ABR threshold and click ABR wave IV 
amplitude. Additionally, there was a weak negative correlation between GAD67-ir terminal 
optical density and age, indicating that as the animals aged, their GAD67 staining decreased. 
These findings indicate that GAD67 levels decrease with age; specifically, the findings suggest 
that there is an age-related decline in GAD67 inside GABAergic terminals. This supports our 
GAD67 hypothesis and adds to the mounting evidence that GAD67 and GABA in the IC 
decrease with age (Helfert et al., 1999; Nakamoto et al., 2013; Ouda & Syka, 2012; Pollak et al., 
2011).  
We also found that GAD67-ir terminal area was not well predicted by age, click ABR 
threshold, tone ABR threshold, and click ABR wave IV amplitude. Further, the relationship 
between GAD67-ir terminal area and age, while significant, was extremely small. Thus, while 
GAD67 levels do decrease with age, the size of GABAergic terminals does not change during 
aging.  
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Aging and Glutamatergic Terminals 
Because inhibition is generally believed to be more important than excitation in the IC, 
very little previous research has focused on glutamate in the IC (Felix II et al., 2015; LeBeau et 
al., 2001; Palombi & Caspary, 1996; Pollak et al., 2011). As such, this is the first study to 
examine the link between aging and glutamatergic terminals in the IC. We found similar results 
for VGluT2 as for GAD67. VGluT2-ir terminal area was only weakly predicted by age, click 
ABR threshold, tone ABR threshold, and click ABR wave IV amplitude. Further, there was no 
significant correlation between VGluT2-ir terminal size and age. Hence, the size of 
glutamatergic terminals does not change with age.  
However, like GAD67-ir terminals, we found that VGluT2-ir terminal staining intensity 
was strongly predicted by age and the three functional auditory measures. Age and tone ABR 
threshold were the best predictors for VGluT2 optical density. Additionally, there was a 
moderately-sized negative correlation between age and VGluT2-ir terminal staining intensity. 
Although no others have considered the changes in VGluT2 protein expression, these findings 
align with the finding in Tadros et al. (2007) that VGluT2 mRNA expression decreases with age. 
We may thus conclude for the first time that there is an age-related decline in VGluT2 levels, and 
possibly glutamate levels, in the ICc.  
It is possible that the VGluT2 changes are indicative of something other than a change in 
glutamate levels. For example, the decrease in VGluT2 optical density may only be indicative of 
an age-related change in concentration of glutamate in vesicles. Alternatively, the decrease in 
VGluT2 optical density may be representative of a decrease in vesicle number. Nevertheless, 
although the two alternative hypotheses may not represent a decrease in glutamate levels, they 
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represent a change in glutamate functionality, at least partially supporting our VGluT2 
hypothesis.  
Aging and Inhibition—Excitation Balance  
Other studies have assessed the relationship between excitatory synapses and inhibitory 
synapses and the functional relationship between inhibitory events and excitatory events, but 
none have considered the effect of aging on the relationship (Casseday et al., 2000; LeBeau et 
al., 2001; Palombi & Caspary, 1996; Nakamoto et al., 2013). We found that age was not 
correlated with the ratio between GAD67-ir and VGluT2-ir terminal area or the ratio between 
GAD67-ir and VGluT2-ir terminal staining intensity. However, both ratios were strongly 
predicted by a model involving age, click ABR threshold, tone ABR threshold, and click ABR 
wave IV amplitude, and the largest independent effect is that of age. Thus although the 
inhibition—excitation balance does not change significantly with age, age and the inhibition—
excitation balance are somewhat related. Hence, our ratio hypothesis is partially supported.  
Aging and Auditory Function 
The decrease in peripheral auditory system function seen here is consistent with previous 
research (Ng et al., 2015; Parthasarathy et al., 2014). The increase in both click and tone ABR 
thresholds indicates the animals’ decreasing ability to hear low intensity and high frequency 
stimuli (Engle et al., 2015; Ng et al., 2015; Parthasarathy et al., 2014). Moreover, the increase in 
threshold was correlated with aging (Engle et al., 2015; Ng et al., 2015; Parthasarathy et al., 
2014). 
Changes in central auditory system function, and particularly in IC function, are 
illustrated in the wave IV amplitudes found in the current study. There is debate in the field at 
this time about whether or not ABR wave amplitudes are correlated with ABR thresholds (Engle 
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et al., 2014; Parthasarathy et al., 2014). The question is important because if the two are not 
correlated it indicates a clear divide between peripheral auditory system function and central 
auditory system function (Parthasarathy et al., 2014). We found no relationship between click 
ABR wave IV amplitude and age or tone ABR threshold. However, in the current study, click 
ABR wave IV amplitude was very strongly correlated with click ABR threshold, indicating that 
as threshold increased, wave IV amplitude decreased. Hence, this finding supports the idea that 
there is not a clear independence between aging of the peripheral and central auditory systems. 
Nevertheless, there was a moderate-strength negative correlation between click ABR 
wave IV amplitude and the GAD67: VGluT2 ratios for both terminal area and terminal optical 
density. This indicates that as the wave IV amplitude decreased, the ratios increased. There were 
no correlations between the ratios and age or either ABR threshold. Thus, because previous 
studies have shown that increased wave IV amplitude is associated with increased IC activity, 
this finding indicates that the inhibition—excitation balance is important to proper IC function 
(Parthasarathy et al., 2014; Stockard & Rossiter, 1977; Engle et al., 2014). Neither GAD67 levels 
nor VGluT2 levels alone were associated with wave IV amplitude, and consequently only one-
third of the wave IV amplitude hypothesis was supported.  
Neuroanatomical Findings 
Contrary to the finding in the tests of auditory function, the neuroanatomical findings 
support a division between the peripheral and central auditory systems. The lack of major 
differences between the ICcv and the ICcd, which respond most strongly to high frequencies and 
low frequencies respectively, suggests an independent view of central auditory system aging 
(Clopton & Winfield, 1973). Because the hair cells that respond to high frequencies deteriorate 
first with aging, it would be expected that the corresponding portions of the ICc would age faster 
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than other portions because they lost their peripheral inputs earlier (Ng et al., 2015). The lack of 
disparity between the two regions of the ICc hence indicates that the aging of the IC is a process 
independent from peripheral aging and loss of peripheral inputs. This finding adds to literature in 
support of that independence (Ouda & Syka, 2012; Parthasarathy et al., manuscript in 
preparation; Parthasarathy et al., 2014).  
We also found that there is little variation in terminal characteristics in the ICc along the 
sagittal or anterior—posterior axis. There was a small negative correlation between distance 
from bregma and VGluT2-ir terminal staining intensity exclusively in aged rats. This suggests 
that more glutamatergic terminals in the anterior part of the ICc deteriorate with age than 
glutamatergic terminals in the posterior part of the ICc, causing a gradient to emerge exclusively 
in aged rats. More research is necessary to determine if there is actually anterior—posterior 
organization of the glutamatergic terminals in the aged ICc, and to uncover how that 
organization arises.  
Limitations and Future Studies 
 Only 6 of the 8 animals underwent all of the tests and measurements. Two animals, one 
young and one aged, were stained only for GAD67. Additionally, it is important to note that the 
current study includes novel findings, but is strictly correlational. More research is necessary to 
bolster the original findings. Chiefly, more studies should investigate the age-related changes in 
VGluT2 and glutamate in the IC, as well as the IC inhibition—excitation relationship.  
 We propose a set of experiments that could be used to demonstrate a causal relationship 
between the IC inhibition—excitation balance and auditory temporal resolution, one function of 
the central auditory system (Mazelová et al., 2003). Temporal resolution, the ability of an animal 
to use precise timing information in auditory processing, is believed to decrease with aging 
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(Felix II et al., 2015; Li-Korotky, 2012; Ozmeral et al., 2016). Previous studies have shown that 
the IC is very important to temporal resolution, and that excitatory and inhibitory events shape 
temporal responses together (Casseday et al., 2000; Felix II et al., 2015; Walton et al., 1997). 
Thus, it is possible that the ratio between GABA expression and glutamate expression in the IC 
is important to temporal processing. Temporal resolution can be tested in animal models through 
the use of a gap detection test. In the test, an animal learns that a foot shock is always preceded 
by a noise with a “gap” in it; gaps can be either tones or silences (Felix II et al., 2015). The 
researcher can adjust the size of the gap and determine the threshold at which the gap is too short 
for the animal to hear by observing the animal’s anticipatory freezing behavior (Felix II et al., 
2015).  
 We propose disrupting the inhibition—excitation balance in a model animal species and 
then using the gap detection test to measure temporal resolution. The balance may be disrupted 
in many ways. For example, we may use genetically engineered cre-lox mice to knock out 
GABAergic or glutamatergic projections to the IC once animals reach adulthood (Hoess & 
Abremski, 1985). Alternatively, we may use surgically targeted drug administration to inactivate 
GABAergic or glutamatertic projections to the IC (Felix II et al., 2015). We could compare the 
gap detection abilities of animals lacking only GABAergic inputs to the IC, only glutamatergic 
inputs to the IC, and lacking both GABAergic and glutamatergic inputs to the IC. Depending on 
the method of balance disruption, a histological assay such as immunofluorescent staining could 
be used to determine the inhibition: excitation ratio in the IC post-mortem. We expect that 
without inhibitory input to the IC, temporal resolution will decrease, as seen in Felix et al. 
(2015). Additionally, we expect that without excitatory input to the IC, temporal resolution will 
decrease. Finally, we believe that if we can knock out or functionally inactive some inhibitory 
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and excitatory inputs to the IC but maintain the IC inhibition—excitation balance, we will see 
relatively normal gap detection ability and temporal resolution.  
Therapies for the Aging Auditory System 
 Although AHRL affects millions of people and is associated with a decrease in many 
quality-of-life factors, less than half of people over 70 years old report being tested for hearing 
ability in the last five years (Bainbridge & Wallhagen, 2014; Lin et al., 2011; Lin et al., 2013; 
Pronk et al., 2013; Pronk et al., 2014). Further, the commonly used diagnostic techniques are 
inadequate (Bainbridge & Wallhagen, 2014). The most commonly used measures of hearing 
loss, such as pure-tone audiometry, assess the ability of the person to perceive sounds at specific 
single tones (kHz) and intensities (dB) in a quiet room (Bainbridge & Wallhagen, 2014). 
However, the resulting audiograms are not necessarily representative of the person’s functional 
hearing ability (Bainbridge & Wallhagen, 2014). For example, many people without 
audiometrically classifiable hearing loss complain of difficulty understanding speech 
(Bainbridge & Wallhagen, 2014; Paglialonga et al., 2013). Speech sounds fall primarily in the 
0.25-3 kHz range, but some consonants have higher frequencies and thus become 
undistinguishable as high frequency perceptual ability decreases with age (Bainbridge & 
Wallhagen, 2014). Additionally, classic audiograms do not take the central auditory system into 
account (Li-Korotky, 2012; Mazelová et al., 2003). The central auditory system is essential to 
understanding speech because it processes temporal aspects of sound and separates the important 
stimuli from a noisy background (John et al., 2012; Li-Korotky, 2012).  
 Regular diagnostic tests and screens addressing the central auditory system should be 
instituted widely to address this problem. Detection of sound in noise is believed to be a task of 
the efferent nerves projecting from the superior olive to the cochlea; sound-in-noise detection is 
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known to become more difficult during aging (Ahmadi, 2010; Giraud et al., 1997; Li-Korotky, 
2012). In the last ten years, using speech-in-noise tests in the clinical setting has become slightly 
more commonplace (Paglialonga et al., 2013). Recently, the “Speech Understanding in Noise” 
(SUN) test has been proposed, which has excellent test-retest reliability and takes less than a 
minute to perform (Paglialonga et al., 2013). The SUN test presents words with intervocalic 
consonants, such as “metal,” against speech-shaped background noise with an increasing signal-
to-noise ratio. Patients must select from a list of three options which word they heard 
(Paglialonga et al., 2013). Because speech perception in a noisy environment is one of the 
primary hearing complaints in aging, people should be tested using SUN or another speech-in-
noise test regularly throughout aging (Paglialonga et al., 2013). 
 Temporal processing ability is another facet of central auditory system aging that can be 
tested (John et al., 2012). Temporal resolution is known to be a function of the IC, as discussed 
above, and is correlated with a person’s ability to distinguish speech sounds (Felix II et al., 2015; 
John et al., 2012). For example, the small gap associated with the /p/ phoneme is the only 
distinguishing feature between the words “soon” and “spoon” (John et al., 2012). Temporal 
processing and gap detection are not assessed in basic audiometric tests (John et al., 2012). Gap-
in-noise tests are the human equivalent of gap detection tests; the listener simply indicates 
whether or not they noticed a small silence in between tones or bursts of noise (John et al., 
2012). Although they are used frequently in research and require no special equipment, gap-in-
noise tests are rarely used in the clinical setting (John et al., 2012).  A quick, simple gap-in-noise 
test should be developed for regular clinical screenings. 
Once AHRL is detected, there are several technologies available that alleviate the 
symptoms. The most common treatment technology is a hearing aid; about 20% of hearing 
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impaired people use hearing aids (Kochkin, 2000; Li-Korotky, 2012). Hearing aids act like a 
microphone for the environment, the speaker pointing directly into the ear (Plomb, 1978). 
Unfortunately, hearing aids only address one part of peripheral ARHL, insensitivity to low 
intensities (Plomb, 1978). Wearing a hearing aid does not increase the range of frequencies one 
can hear or address the central auditory system aspects of ARHL (Li-Korotky, 2012; Plomb, 
1978). Because of these limitations, about 16% of people who own hearing aids do not wear 
them (Kochkin, 2000). The signal detection in noise is particularly problematic to these non-
wearers (Kochkin, 2000). 25% of non-wearers who responded to an open-ended question about 
why they do not use their hearing aids cited signal-in-noise detection problems (Kochkin, 2000). 
However, hearing aids have been shown to increase quality of life in people with ARHL by 
increasing their interaction with their environment and the people around them (Acar et al., 2011; 
Boi et al. 2012).  
Cochlear implants are slightly better at addressing the problem of sound-in-noise 
detection (Friesen et al., 2001). Cochlear implants have two primary parts: an external speech 
processor and one or more electrodes (Wilson et al., 1991). The external speech processor 
receives inputs in the same way as a hearing aid, but instead of simply outputting the amplified 
inputs, it transduces the inputs into electrical stimuli that can be transmitted by the electrodes 
(Wilson et al., 1991). The electrodes then electrically activate the cochlear nerve (Wilson et al., 
1991). Cochlear implants have been shown to increase speech understanding in both quiet and 
noisy settings (Friesen et al., 2001; Wilson et al., 1991). However, cochlear implants are 
typically only used in individuals with severe hearing loss and do not fully restore ability 
(Friesen et al., 2001; Wilson et al., 1991). There are yet more technologies useful to hearing loss, 
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including auditory brainstem implants, but they are rare and seldom used for ARHL (Rosahl & 
Rosahl, 2016).  
 Better testing of ARHL is not only essential for symptom treatment purposes: there are 
preventative measures and reversal training regimens available (Anderson et al., 2012). Turner et 
al. (2013) demonstrated that an enriched or augmented acoustic environment contributes to 
preventing ARHL (Turner et al., 2013). They found that aged mice exposed to controlled 
broadband noise for their awake hours for six weeks performed better in auditory tests related to 
both peripheral and central auditory systems, and had increased GAD67 levels in the IC (Turner 
et al., 2013). Creating enriched acoustic environments in nursing homes and assisted living 
facilities would be relatively simple and could prevent further ARHL in the residents. Further, 
discrimination training may actually reverse auditory deficiencies in those with ARHL 
(Anderson et al., 2012). Discrimination training combines auditory perception discrimination 
tasks with cognitive tasks, and has been shown to increase speech-in-noise perception, 
processing speed, and memory after just 8 weeks of training (Anderson et al., 2012). Greater 
awareness of these preventative and treatment options is essential to addressing the public health 
concern ARHL (Li-Korotky, 2012). 
Therapies for the Aging Brain 
Aging is a normal part of life; however, it may be possible to delay its onset, decrease its 
mechanisms and symptoms, and extend the lifespan.  Doing so would remove the need for 
therapies for specific systems, including the auditory system. Although there are many possible 
cellular and molecular targets to reduce or delay aging, two particularly intriguing approaches 
are considered here. 
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One essential aspect of aging is cellular senescence, the irreversible stress-induced arrest 
of cell growth (Baker et al., 2016). Many of the stressors that trigger cell senescence are 
oncogenic; thus, cell senescence is believed to be a programmed method for avoiding tumor 
development (Childs et al., 2014). However, senescent cells express a very specific group of 
secretary substances, including cytokines and chemokines, which cause inflammation; matrix 
metalloproteinases, which degrade extracellular proteins; and growth factors (Baker et al., 2016). 
This group of secretary substances, known collectively as the senescence-associated secretory 
phenotype (SASP), may actually contribute to tumor development and tissue degradation (Childs 
et al., 2014). Additionally, when stem and progenitor cells become senescent, they are 
irreversibly prohibited from performing their biological function (Baker et al., 2016). 
Because only senescent cells express the p16Ink4a gene (INK), it is possible to target them 
genetically (Baker et al., 2016). Baker et al. (2016) revealed that interruption of senescent cell 
accumulation in BubR1 mice, a strain that develops many age-related disorders, postpones the 
onset of age-related disorders. Baker et al. (2016) have developed a senescence-targeting therapy 
that may be effective in delaying aging and the onset of age-related disorders. They utilize the 
transgene INK-ATTAC to exclusively target cells when they enter senescence (Baker et al., 
2016). The INK-ATTAC gene, which is incorporated into the mouse’s own genome, consists of 
the INK gene with a novel gene called Apoptosis Through Targeted Activation of Caspase-8 
(ATTAC) in the promoter region (Baker et al., 2016; Trujillo et al., 2005). Once ATTAC has 
been translated, the drug AP20187 is administered generally to the animal (Baker et al., 2016; 
Childs et al., 2014). AP20187 is an artificial ligand for the FKBP domain of caspase-8; it 
facilitates the dimerization of caspase-8, causing caspase-8 activation and the selective apoptosis 
of senescent cells (Baker et al., 2016; Childs et al., 2014).  
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Baker et al. (2016) showed that INK-ATTAC/AP20187-mediated clearance of senescent 
cells increased lifespan in two different mouse strains. However, it did not affect the function of 
glomeruli in the kidney, potassium-ATP channels in the heart, or adipocytes cells, several of the 
most concerning possible side effects (Baker et al., 2016). Another treatment concern is related 
to the one positive role senescent cells play in normal animals. Senescent cells aid in tissue 
remodeling, such as during wound healing and emdryogenesis (Baker et al., 2016). Baker et al. 
(2016) found that if AP20187 administration was stopped during wound repair, the wound 
healed normally, regardless of previous INK-ATTAC/AP20187-mediated clearance. It appears 
that aging treatment using INK-ATTAC/AP20187-mediated clearance of senescent cells may be 
a productive, viable, and safe option, but more research—especially in non-human primates and 
humans—is essential.  
Another group of researchers is attempting different approach. The pleiotropic protein 
klotho appears to delay aging and increase cognitive function (Dubal et al., 2015; Tsujikawa et 
al., 2003). Although it is primarily being studied in relation to Alzheimer’s disease (AD), this 
treatment could be useful to treat aging broadly. Klotho levels decrease with age and progression 
of AD, as seen in non-human primates and human cerebrospinal fluid studies (Duce et al., 2008; 
Semba et al., 2014). Klotho, which produced by the choroid plexus in the brain and the distal 
tubule cells of the kidney, is involved in degradation of myelin in non-human primates (Dubal et 
al., 2015; Duce et al., 2008; Tsujikawa et al., 2003). Likewise, transgenic klotho-deficient mice 
have less myelin, fewer functional synapses, and decreased cognitive ability (Dubal et al., 2015). 
They also have many age-related bodily conditions including osteoporosis, infertility, 
arteriosclerosis, emphysema, and shortened lifespan (Carpinelli et al., 2011). Humans that 
overproduce klotho have longer lifespans and larger prefrontal cortexes (Dubal et al., 2015). 
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Dubal et al., (2015) found that dual transgenic mice that overproduce amyloid precursor protein 
(APP) and overproduce klotho manage to escape the AD-like symptoms normally seen in APP-
overproducing mice: they had normal length lifespans, normal APP levels, and no significant 
cognitive, behavioral, or synaptic deficiencies. 
There is also evidence that klotho treatment would have an impact on ARHL. Klotho-
deficient mice exhibit mild hearing loss, in addition to their other premature aging symptoms 
(Carpinelli et al., 2011). The tone and click ABR thresholds in klotho-deficient mice were 14-18 
dB higher than those of wild-type mice (Carpinelli et al., 2011). However, histology of the 
cochlea of klotho-deficient mice showed no abnormalities in to the organ of Corti, hair cells, 
Rosenthal’s canal, or spiral ganglion neuron densities (Carpinelli et al., 2011). Tsujikawa et al. 
(2003) found that the premature aging seen in klotho-deficiency might actually be a downstream 
effect of increased calcitriol. Calcitriol, a form of vitamin D, is inactivated in the kidney by 
fibroblast growth factor 23 (FGF23); FGF23’s action is mediated by klotho (Prié & Friedlander, 
2010). Thus, klotho-deficient mice are unable to properly inactivate calcitriol (Tsujikawa et al., 
2003). Carpinelli et al. (2011) found that feeding klotho-deficient mice a vitamin D deficient diet 
from conception prevented many of the aging phenotypes associated with a klotho deficiency, 
including the presbycusis-like phenotype. Although klotho research is in its infancy, the concept 
is intriguing and could be useful in treating many aspects of aging, including AD and 
presbycusis.  
Conclusion 
 Aging is currently an important research topic because large cohorts around the world, 
like the “baby boomers” in the United States, are approaching old age (Halaweish & Alam, 
2014; Ortman et al., 2014; Raichlen & Alexander, 2014). Understanding and developing 
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therapies for the aging auditory system is essential due to the high occurrence and major 
psychosocial implications of age-related hearing loss, or presbycusis (Lin et al., 2011; Lin et al., 
2013; Pronk et al., 2013; Pronk et al., 2014). The major novel findings of this study, glutamate 
expression in the ICc decreases with age and the inhibition—excitation balance in the ICc is 
related to click ABR wave IV amplitude and IC function, add to the understanding of this 
problem. However, more work on the aging IC, the central auditory system, and the brain are 
required to develop effective aging therapies.  
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Afterward  
Although I began my undergraduate studies as a voice performance major, I am much 
happier now as a neuroscientist. I discovered my affinity for neuroscience in the lab and courses 
of Dr. Akshat Vyas. However, after he was terminated from the university due to a series 
dangerous psychotic episodes, I reclaimed my love for the field in the labs of Dr. Ed Bartlett and 
Dr. Stephanie Gardner at Purdue University. Drs. Bartlett and Gardner have been excellent, 
steady mentors since May of 2014.  
In conjunction with my major thesis Alzheimer’s Disease: The Emperor of All 
Dementias, this work represents the culmination of my undergraduate studies. Hopefully before I 
leave for graduate school, I will have submitted two papers for publication: the d-galactose study 
I worked on with Drs. Parthasarathy and Bartlett and the research portion of this thesis.  
Next year I will be joining the University of Pennsylvania’s Neuroscience Graduate 
Group to pursue my PhD in Neuroscience. At this time, U Penn’s program is a top ten 
neuroscience graduate program. I am looking forward to my matriculation and am currently 
considering rotations with Drs. Kelly Jordan-Sciutto, Sangwon Kim, Tracey Bale, Nancy Bonini, 
and Tom Jongens. I plan to study the molecular and cellular mechanisms of neurodegenerative 
diseases or neurodevelopmental diseases and conditions. I am a 2016 National Science 
Foundation Graduate Research Fellow. I hope to someday hold a tenured position as a faculty 
member with both research and teaching responsibilities.  
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Appendix A 
 List of Abbreviations 
   ABR Auditory brainstem response 
AD Alzheimer’s disease 
AHRL Age-related hearing loss 
APP Amyloid precursor protein 
ATTAC Apoptosis Through Targeted Activation of Caspase-8 
ChAT Choline acetyltransferase 
dB; dB SPL Decibels sound pressure level; the unit of intensity for sound 
DNA Deoxyribonucleic acid 
FDOPA PET Fluorodopa positron emission tomography 
FGF23 Fibroblast growth factor 23 
FSIQ Full scale IQ 
GABA Gamma-aminobutyric acid 
GAD Glutamate decarboxylase 
Grik3 Gene encoding glutamate receptor inotropic kainite 3 
Hz Hertz; the unit of frequency for sound 
IC Inferior colliculus 
ICc Central nucleus of the inferior colliculus 
INK p16Ink4a gene; selectively expressed in senescent cells 
IQ Intelligence quotient 
-ir -immunoreactive 
LASA Longitudinal Aging Study Amsterdam 
MBP Myelin basic protein 
MOG Myelin oligodendrocyte glycoprotein 
mRNA Messenger ribonucleic acid 
OCT compound Optimal cutting temperature compound 
PACUC Purdue Animal Care and Use Committee 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
Pycs Gene encoding pyrroline-5-carboxylate synthetase 
Slc1a2 Gene encoding excitatory amino-acid transporter 2 
Slc1a3 Gene encoding excitatory amino-acid transporter 1 
Slc17a6 Gene encoding vesicular glutamate transporter 2 
VGluT Vesicular glutamate transporter 
WAIS Wechsler Adult Intelligence Scales 
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Appendix B 
Protocol for Secondary Immunofluorescent Staining 
In a 24-well plate, slices were rinsed twice with phosphate buffered saline (PBS) to remove OCT 
compound. 150 µl of blocking solution was then added to each well and slices were incubated on 
a shaker for thirty minutes. Blocking solution is 0.25% Triton X-100 detergent, used to disrupt 
the cell membranes slightly so antibodies may enter; 5% normal goat serum, used to cover non-
target surfaces and prevent nonspecific binding of antibodies; and 94.75% PBS. After the thirty 
minutes, the blocking solution was removed and 150 µl of primary antibody solution was added 
to each well except for the first negative control. Primary antibody solution consists of 0.2% 
mouse anti-GAD67 antibody, 0.2% guinea pig anti-VGluT2 antibody, and 99.6% antibody 
solution; antibody solution is 0.25% Triton X-100 detergent, 1% normal goat serum, and 98.75% 
PBS. The 24-well plate was covered in parafilm, incubated on a shaker for 10 minutes, and then 
placed in a 4°C refrigerator to incubate overnight. The next day, the tissue was rinsed three more 
times with PBS before adding 150 µl of secondary antibody solution to each well. Secondary 
antibody solution consists of 1% goat anti-mouse antibodies conjugated to the Alexa Fluor 488 
dye, 1% goat anti-guinea pig antibodies conjugated to the Alexa Fluor 633 dye, and 98% 
antibody solution. The tissue was incubated on a shaker for 60 minutes in low light, so as not to 
damage the fluorescent molecules. Finally, the tissue was rinsed three more times with PBS, 
transferred to distilled H2O, mounted on slides, and coverslipped.  
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